ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2
Published in
European Heart Journal - Cardiovascular Pharmacotherapy, April 2022
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2023.
All research outputs
#1,975,584
of 32,836,612 outputs
Outputs from European Heart Journal - Cardiovascular Pharmacotherapy
#163
of 713 outputs
Outputs of similar age
#37,543
of 465,727 outputs
Outputs of similar age from European Heart Journal - Cardiovascular Pharmacotherapy
#4
of 20 outputs
Altmetric has tracked 32,836,612 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 713 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.9. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 465,727 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.
